IB Acquisition Corp.
corporate_fare Company Profile
IB Acquisition Corp. (NASDAQ:IBAC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for IBAC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-06, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for IBAC spans 8-K, 8-K/A, 425, DEF 14A.
Recent high-impact activity:
- Nasdaq Flags IB Acquisition Corp. for Missing Annual Meeting Deadline
- Full Commitment Note Terms and Sponsor Lock-Up Release Disclosed by IB Acquisition Corp.
- Commitment Note Terms and $90M PIPE Financing Quantified in Latest Filing
- GNQ InSilico, IBM, and AWS Launch Quantum-Infused Biomedical Reasoning Platform
- IB Acquisition Secures $50M Equity Line, Sets Post-Merger Ticker 'GNQI'
Financial Snapshot
Short Interest & Short Volume
14.27 days to coverFINRA reported short interest of 2,411 shares in IBAC as of the October 30, 2026 settlement, a 0.4% increase from the prior period — about 14.3 days to cover at its recent average daily volume. On November 19, 2026, 100.0% of IBAC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.